The notices it replaced
- Reissues: PAR-21-331 Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $716,332 in first-year total cost, median $716,332.
Most frequent study sections
- Cancer Prevention Study Section[CPSS]1
Most frequent institutions
- VANDERBILT UNIVERSITY MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery1R01CA275864-01A1 · under PAR-21-331 | FLYNN, CHARLES RSHU, XIAO-OUYU, DANXIA | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $716,332 | CPSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.